ClinicalTrials.Veeva

Menu

Marwo-D Research -Need for Vitamin D in Different Population Groups (ODIN)

U

University of Helsinki

Status

Completed

Conditions

Serum 25-hydroxyvitamin D Concentrations (25OHD)

Treatments

Dietary Supplement: Vitamin D3

Study type

Interventional

Funder types

Other

Identifiers

NCT02212223
Helsinki U

Details and patient eligibility

About

Insufficient intake of vitamin D is a public health problem, affecting about 40% of the Finnish population in the winter. Vitamin D has a wide range of health effects: in addition to its effect on bone, it is known to affect inflammatory response among other things. The sources of vitamin D are the synthesis in the skin as well as diet and dietary supplements. In Finland and in Northern Europe vitamin D is formed in the skin only from March to October. This alone is not sufficient to cover the need for year-round, because vitamin D storage is used in a few months. During the winter months the only sources of vitamin D are diet and vitamin preparations. Current vitamin D recommendations are usually based on studies in white population. However, there can be a difference in the need of vitamin D and in vitamin D metabolism between different population groups. More research evidence is needed from the northern countries. The aim of this study is to evaluate the vitamin D need in Somali immigrant population and in original Finnish population. The hypothesis is that the Somalis need more vitamin D to exceed the serum 25(OH)D concentration of 50 nmol/L than the original Finnish population.

Enrollment

147 patients

Sex

Female

Ages

21 to 66 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • woman between 21-66 years of age
  • belongs to original Finnish population or to Somali immigrant population
  • healthy (= no disease requiring medication)
  • lives in the metropolitan area

Exclusion criteria

  • pregnant or breastfeeding
  • has traveled to a sunny destination or destination near the equator during the previous month
  • plans to travel to a sunny destination or destination near the equator in the next 6 months
  • has used a tanning bed during the previous month
  • plans to use a tanning bed in the next 6 months
  • the subject's blood 25-hydroxy-vitamin D level (25 (OH) D), exceeds 100 nmol / L or is less than 30 nmol / L at baseline in the screening phase.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

147 participants in 6 patient groups, including a placebo group

Group 1: Somali immigrant group, 10 µg (400 IU) vitamin D3
Experimental group
Description:
Subjects belonging to Somali immigrant population are given a daily supplement containing 10 µg (400 IU) vitamin D3 to take for 6 months
Treatment:
Dietary Supplement: Vitamin D3
Group 2: Somali immigrant group, 20 µg (800 IU) vitamin D3
Experimental group
Description:
Subjects belonging to Somali immigrant population are given a daily supplement containing 20 µg (800 IU) vitamin D3 to take for 6 months
Treatment:
Dietary Supplement: Vitamin D3
Group 3: Somali immigrant group, 0 µg vitamin D3
Placebo Comparator group
Description:
Subjects belonging to Somali immigrant population are given a daily supplement containing 0 µg (0 IU) vitamin D3 to take for 6 months
Group 4: Original Finnish group, 10 µg (400 IU) vitamin D3
Experimental group
Description:
Subjects belonging to original Finnish population are given a daily supplement containing 10 µg (400 IU) vitamin D3 to take for 6 months.
Treatment:
Dietary Supplement: Vitamin D3
Group 5: Original Finnish group, 20 µg (800 IU) vitamin D3
Experimental group
Description:
Subjects belonging to original Finnish population are given a daily supplement containing 20 µg (800 IU) vitamin D3 to take for 6 months.
Treatment:
Dietary Supplement: Vitamin D3
Group 6: Original Finnish group, 0 µg vitamin D3
Placebo Comparator group
Description:
Subjects belonging to original Finnish population are given a daily supplement containing 0 µg (0 IU) vitamin D3 to take for 6 months.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems